BiOSS Study (BiOSS LIM C Stent Registry in Bifurcated Lesions) (BIOSS)

Vall d'Hebron University Hospital (HUVH)

Status: Unknown

Conditions: Coronary Artery Disease

Treatments: Procedure: Coronary angioplasty with stent implantation

Study type: Observational

Funder types: Other

Identifiers

NCT03475563

BIOSS

Details and patient eligibility

About

The BIOSS Lim C pharmacoactive Stent has characteristics of design that makes it very suitable for the treatment of bifurcational lesions . The objective of the study is providing deeper knowledge into the results of this stent in the treatment of bifurcational lesions.

Full description

The BIOSS Lim C pharmacoactive Stent has characteristics of design that makes it very suitable for the treatment of bifurcational lesions . The objective of the study is providing deeper knowledge into the results of this stent in the treatment of bifurcational lesions.

Enrollment: 100 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Age over 18 years.
• Clinical indication of coronary angioplasty in bifurcated lesion.
• Bifurcated lesions with both distal branches at least 2 mm in diameter.
• The lesion must be located in the main branch, with a severe stenosis by visual estimation at some point in the main branch, with or without involvement of the lateral branch.
• Express acceptance and signature of informed consent.

Exclusion criteria

• Express rejection of the patient to participate in the study.
• Exclusive involvement of the lateral branch (Medina lesion 001).
• Contraindication for antiplatelet treatment.
• Lesions due to restenosis.
• Lesions in saphenous grafts.
• Total chronic occlusions.
• Cardiogenic shock.

Trial design

100 participants in 1 patient group

Patients with coronary artery disease

Description:

(coronary artery disease)

Treatment:

Procedure: Coronary angioplasty with stent implantation